Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 envelope glycoprotein gp120 is a critical component of the viral envelope spike, responsible for mediating virus entry into host cells. The C5 domain represents the carboxy-terminal region of gp120 and plays a key role in the structure and function of the envelope protein, mediating interaction with gp41 and influencing Env maturation. It is a potential drug target for disrupting virus-cell fusion.
Disruption of Env maturation or Env-gp41 association
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 (C5 Domain) (gp120 C5 Domain).